Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Archives of Dermatological Research|June 7, 2024
Anti-tumor effects of tirbanibulin in squamous cell carcinoma cells are mediated via disruption of tubulin-polymerizationViola K DeTemple, Antje Walter, Sabine Bredemeier, et al.Frontiers in Immunology|December 15, 2025
A composite score of serum cytokines enables early identification of patients at high risk for irAEs under immune checkpoint inhibitionNina Flatt, Antje Walter, Corinna Kochanek, et al.Cancers|November 11, 2022
Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 PatientsViola K DeTemple, Jessica C Hassel, Michael M Sachse, et al.European Journal of Cancer (Oxford, England : 1990)|October 10, 2024
Short- and long-term immunosuppressive effects of melanoma influence the prognostic value of the sentinel lymph node statusViola K DeTemple, Cathrin Ritter, Nalini Srinivas, et al.The Journal of Pathology. Clinical Research|January 16, 2026
Alcian blue-positive stromal phenotype in basal cell carcinoma is associated with progression on first-line hedgehog inhibitorsViola K DeTemple, Rudolf Stadler, Sabine Bredemeier, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 17, 2023
S2k Guideline - Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - Update 2022Jürgen C Becker, Ambros J Beer, Viola K DeTemple, et al.European Journal of Cancer (Oxford, England : 1990)|June 28, 2025
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinomaViola K DeTemple, Martin Kaatz, Eggert Stockfleth, et al.Pageof 1